| Literature DB >> 25483490 |
Michelle H Moniz1, Richard H Beigi.
Abstract
Maternal immunization holds tremendous promise to improve maternal and neonatal health for a number of infectious conditions. The unique susceptibilities of pregnant women to infectious conditions, as well as the ability of maternally-derived antibody to offer vital neonatal protection (via placental transfer), together have produced the recent increased attention on maternal immunization. The Advisory Committee on Immunization Practices (ACIP) currently recommends 2 immunizations for all pregnant women lacking contraindication, inactivated Influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap). Given ongoing research the number of vaccines recommended during pregnancy is likely to increase. Thus, achieving high vaccination coverage of pregnant women for all recommended immunizations is a key public health enterprise. This review will focus on the present state of vaccine acceptance in pregnancy, with attention to currently identified barriers and determinants of vaccine acceptance. Additionally, opportunities for improvement will be considered.Entities:
Keywords: AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; ACOG, American College of Obstetricians and Gynecologists; CDC, Centers for Disease Control and Prevention; MMR, measles, mumps, and rubella; Tdap, tetanus toxoid, reduced diphtheria toxoid and acellular pertussis; immunization; influenza; pertussis; pregnancy; vaccination; vaccine
Mesh：
Substances：
Year: 2014 PMID： 25483490 PMCID： PMC4977442 DOI： 10.4161/21645515.2014.970901
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN： 2164-5515 Impact factor: 3.452